APO RESEARCH · REPORT
Heparin Sodium
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Product & engineering
Understand the product.
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Selected research
Industry Research
Heparin Sodium Industry Research Report 2026
Market perspective
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer, Dongcheng Biochemicals, etc. Global top five manufacturers hold a share about 60%. China is the largest market, with a share about 60%, followed by Europe and North America, total with a share about 35 percent. In terms of application, the largest application is Treatment of Venous Thromboembolism, followed by Cardioversion of Atrial Fibrillation/Flutter, and Treatment of Venous Thromboembolism, etc.
Report Scope
Read the full market overview
This report quantifies the global Heparin Sodium market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Heparin Sodium Market by Company
Shenzhen Hepalink
Bioibérica
Nanjing King-friend
Pfizer
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Changshan Biochemical
Pharma Action
Baxter
Dongying Tiandong Pharmaceutical
Opocrin
Aspen Oss
Xinbai Pharmaceuticals
Yino Pharma Limited
Sichuan Deebio
Heparin Sodium Segment by Type
Oral Type
Injection Type
Heparin Sodium Segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Other
Heparin Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Heparin Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Heparin Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Heparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Type
- Injection Type
Applications
- Treatment of Venous Thromboembolism
- Complications of Pregnancy
- Cardioversion of Atrial Fibrillation/Flutter
- Other
Companies covered
- Shenzhen Hepalink
- Bioibérica
- Nanjing King-friend
- Pfizer
- Dongcheng Biochemicals
- Changzhou Qianhong Bio-pharma
- Changshan Biochemical
- Pharma Action
- Baxter
- Dongying Tiandong Pharmaceutical
- Opocrin
- Aspen Oss
- Xinbai Pharmaceuticals
- Yino Pharma Limited
- Sichuan Deebio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Heparin Sodium Market Size (2021-2032)
- 2.2.2 Global Heparin Sodium Sales (2021-2032)
- 2.2.3 Global Heparin Sodium Market Average Price (2021-2032)
- 2.3 Heparin Sodium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Type
- 2.3.3 Injection Type
- 2.4 Heparin Sodium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Treatment of Venous Thromboembolism
- 2.4.3 Complications of Pregnancy
- 2.4.4 Cardioversion of Atrial Fibrillation/Flutter
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Heparin Sodium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Heparin Sodium Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Heparin Sodium Revenue of Manufacturers (2021-2026)
- 3.4 Global Heparin Sodium Average Price by Manufacturers (2021-2026)
- 3.5 Global Heparin Sodium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Heparin Sodium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Heparin Sodium, Product Type & Application
- 3.8 Global Manufacturers of Heparin Sodium, Established Date
- 3.9 Global Heparin Sodium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shenzhen Hepalink
- 4.1.1 Shenzhen Hepalink Company Information
- 4.1.2 Shenzhen Hepalink Business Overview
- 4.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shenzhen Hepalink Heparin Sodium Product Portfolio
- 4.1.5 Shenzhen Hepalink Recent Developments
- 4.2 Bioibérica
- 4.2.1 Bioibérica Company Information
- 4.2.2 Bioibérica Business Overview
- 4.2.3 Bioibérica Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bioibérica Heparin Sodium Product Portfolio
- 4.2.5 Bioibérica Recent Developments
- 4.3 Nanjing King-friend
- 4.3.1 Nanjing King-friend Company Information
- 4.3.2 Nanjing King-friend Business Overview
- 4.3.3 Nanjing King-friend Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nanjing King-friend Heparin Sodium Product Portfolio
- 4.3.5 Nanjing King-friend Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Heparin Sodium Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Dongcheng Biochemicals
- 4.5.1 Dongcheng Biochemicals Company Information
- 4.5.2 Dongcheng Biochemicals Business Overview
- 4.5.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Dongcheng Biochemicals Heparin Sodium Product Portfolio
- 4.5.5 Dongcheng Biochemicals Recent Developments
- 4.6 Changzhou Qianhong Bio-pharma
- 4.6.1 Changzhou Qianhong Bio-pharma Company Information
- 4.6.2 Changzhou Qianhong Bio-pharma Business Overview
- 4.6.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolio
- 4.6.5 Changzhou Qianhong Bio-pharma Recent Developments
- 4.7 Changshan Biochemical
- 4.7.1 Changshan Biochemical Company Information
- 4.7.2 Changshan Biochemical Business Overview
- 4.7.3 Changshan Biochemical Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Changshan Biochemical Heparin Sodium Product Portfolio
- 4.7.5 Changshan Biochemical Recent Developments
- 4.8 Pharma Action
- 4.8.1 Pharma Action Company Information
- 4.8.2 Pharma Action Business Overview
- 4.8.3 Pharma Action Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pharma Action Heparin Sodium Product Portfolio
- 4.8.5 Pharma Action Recent Developments
- 4.9 Baxter
- 4.9.1 Baxter Company Information
- 4.9.2 Baxter Business Overview
- 4.9.3 Baxter Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Baxter Heparin Sodium Product Portfolio
- 4.9.5 Baxter Recent Developments
- 4.10 Dongying Tiandong Pharmaceutical
- 4.10.1 Dongying Tiandong Pharmaceutical Company Information
- 4.10.2 Dongying Tiandong Pharmaceutical Business Overview
- 4.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolio
- 4.10.5 Dongying Tiandong Pharmaceutical Recent Developments
- 4.11 Opocrin
- 4.11.1 Opocrin Company Information
- 4.11.2 Opocrin Business Overview
- 4.11.3 Opocrin Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Opocrin Heparin Sodium Product Portfolio
- 4.11.5 Opocrin Recent Developments
- 4.12 Aspen Oss
- 4.12.1 Aspen Oss Company Information
- 4.12.2 Aspen Oss Business Overview
- 4.12.3 Aspen Oss Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Aspen Oss Heparin Sodium Product Portfolio
- 4.12.5 Aspen Oss Recent Developments
- 4.13 Xinbai Pharmaceuticals
- 4.13.1 Xinbai Pharmaceuticals Company Information
- 4.13.2 Xinbai Pharmaceuticals Business Overview
- 4.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Xinbai Pharmaceuticals Heparin Sodium Product Portfolio
- 4.13.5 Xinbai Pharmaceuticals Recent Developments
- 4.14 Yino Pharma Limited
- 4.14.1 Yino Pharma Limited Company Information
- 4.14.2 Yino Pharma Limited Business Overview
- 4.14.3 Yino Pharma Limited Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Yino Pharma Limited Heparin Sodium Product Portfolio
- 4.14.5 Yino Pharma Limited Recent Developments
- 4.15 Sichuan Deebio
- 4.15.1 Sichuan Deebio Company Information
- 4.15.2 Sichuan Deebio Business Overview
- 4.15.3 Sichuan Deebio Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Sichuan Deebio Heparin Sodium Product Portfolio
- 4.15.5 Sichuan Deebio Recent Developments
5 Global Heparin Sodium Market Scenario by Region
- 5.1 Global Heparin Sodium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Heparin Sodium Sales by Region: 2021-2032
- 5.2.1 Global Heparin Sodium Sales by Region: 2021-2026
- 5.2.2 Global Heparin Sodium Sales by Region: 2027-2032
- 5.3 Global Heparin Sodium Revenue by Region: 2021-2032
- 5.3.1 Global Heparin Sodium Revenue by Region: 2021-2026
- 5.3.2 Global Heparin Sodium Revenue by Region: 2027-2032
- 5.4 North America Heparin Sodium Market Facts & Figures by Country
- 5.4.1 North America Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Heparin Sodium Sales by Country (2021-2032)
- 5.4.3 North America Heparin Sodium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Heparin Sodium Market Facts & Figures by Country
- 5.5.1 Europe Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Heparin Sodium Sales by Country (2021-2032)
- 5.5.3 Europe Heparin Sodium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Heparin Sodium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Heparin Sodium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Heparin Sodium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Heparin Sodium Market Facts & Figures by Country
- 5.7.1 South America Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Heparin Sodium Sales by Country (2021-2032)
- 5.7.3 South America Heparin Sodium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Heparin Sodium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Heparin Sodium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Heparin Sodium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Heparin Sodium Sales by Type (2021-2032)
- 6.1.1 Global Heparin Sodium Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Heparin Sodium Sales Market Share by Type (2021-2032)
- 6.2 Global Heparin Sodium Revenue by Type (2021-2032)
- 6.2.1 Global Heparin Sodium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Heparin Sodium Revenue Market Share by Type (2021-2032)
- 6.3 Global Heparin Sodium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Heparin Sodium Sales by Application (2021-2032)
- 7.1.1 Global Heparin Sodium Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Heparin Sodium Sales Market Share by Application (2021-2032)
- 7.2 Global Heparin Sodium Revenue by Application (2021-2032)
- 7.2.1 Global Heparin Sodium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Heparin Sodium Revenue Market Share by Application (2021-2032)
- 7.3 Global Heparin Sodium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Heparin Sodium Value Chain Analysis
- 8.1.1 Heparin Sodium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Heparin Sodium Production Mode & Process
- 8.2 Heparin Sodium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Heparin Sodium Distributors
- 8.2.3 Heparin Sodium Customers
9 Global Heparin Sodium Analyzing Market Dynamics
- 9.1 Heparin Sodium Industry Trends
- 9.2 Heparin Sodium Industry Drivers
- 9.3 Heparin Sodium Industry Opportunities and Challenges
- 9.4 Heparin Sodium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst